- Live market news
- Stocks
- PYXS
Pyxis Oncology, Inc. Common Stock
PYXSStockUnited States
Latest news on PYXSranked by Oyticker for market impact
- 45Impact
PYXS Prices $110M Public Offering with $172.6M Warrant Upside
Pyxis Oncology priced a registered public offering of 36.0M common shares and 1.9M pre-funded warrants at $2.90/share plus warrants, raising ~$110M gross proceeds with potential $172.6M additional if all warrants exercise at $3.50.
PYXSBiotechnologyOncology - 45Impact
Pyxis Oncology launches registered public offering of common stock and warrants
PYXS, a clinical-stage oncology company, commenced a registered public offering of common shares (or pre-funded warrants) bundled with common warrants. The offering structure suggests capital raise to fund development pipeline.
PYXSBiotechnologyOncologyCapital Markets
What PYXS filed
- 5 Nov 2026
- 5 Nov 2026
- 21 Oct 2026
- 1 Oct 2026
Other event
- 9 Sept 2026
Other event
- 8 Sept 2026
Investor communication
- 13 Aug 2026
- 13 Aug 2026
- 2 Jul 2026
Unregistered share sale · Investor communication
- 15 Jun 2026
- 14 May 2026
- 14 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.